PFIZER THAILAND LIMITED

Company Introduction: Pfizer Thailand Limited

Please note that Pfizer Thailand Limited is based in Thailand, not Singapore. While Pfizer has a significant presence in Singapore through Pfizer Singapore Pte Ltd, Pfizer Thailand Limited operates within Thailand.

Pfizer Thailand Limited is a subsidiary of Pfizer Inc., a global pharmaceutical and biotechnology corporation. Its primary role in Thailand involves the marketing, sales, and distribution of Pfizer's innovative medicines, vaccines, and healthcare products to patients and healthcare providers across the country. The company is dedicated to improving health and well-being through its pharmaceutical portfolio. It also engages in clinical research and development activities to bring new treatments to the Thai market and ensures compliance with local health regulations.

Factory or Trading Company:

Pfizer Thailand Limited primarily functions as a trading and distribution company. It is responsible for importing, marketing, and selling Pfizer's global product portfolio within Thailand. While large pharmaceutical companies like Pfizer do operate manufacturing facilities (factories) worldwide, Pfizer Thailand Limited's main operational identity in the Thai market is focused on commercial activities, including sales, marketing, and distribution. It may oversee local packaging or contract manufacturing operations, but its core business model in Thailand is that of a pharmaceutical distributor and marketer.

Pfizer Thailand Limited operates in Thailand. However, if you are interested in products manufactured or sold by Pfizer in Singapore, the company offers a wide range of pharmaceutical products across various therapeutic areas through its local operations.

Here are some examples of products and therapeutic areas generally available from Pfizer in Singapore:

Vaccines:

Prevenar 13 (Pneumococcal Vaccine)

Comirnaty (COVID-19 Vaccine)

Oncology (Cancer Treatment):

Ibrance (palbociclib)

Xalkori (crizotinib)

Sutent (sunitinib)

Inlyta (axitinib)

Xtandi (enzalutamide)

Internal Medicine and Cardiovascular:

Eliquis (apixaban)

Lipitor (atorvastatin)

Viagra (sildenafil)

Celebrex (celecoxib)

Lyrica (pregabalin)

Inflammation and Immunology:

Xeljanz (tofacitinib)

Anti-Infectives:

Zosyn (piperacillin and tazobactam)

Vfend (voriconazole)

Rare Disease:

Vyndaqel (tafamidis)

This list is not exhaustive, as Pfizer has a broad portfolio that may vary based on market approvals and local availability.